Sotera Health Co (SHC)
11.27
-0.11
(-0.97%)
USD |
NASDAQ |
Apr 24, 16:00
11.26
-0.01
(-0.09%)
After-Hours: 20:00
Sotera Health Cash from Financing (TTM): 265.96M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 265.96M |
September 30, 2023 | 469.00M |
June 30, 2023 | 472.05M |
March 31, 2023 | 472.13M |
December 31, 2022 | 197.76M |
September 30, 2022 | -3.265M |
June 30, 2022 | -106.28M |
Date | Value |
---|---|
March 31, 2022 | -113.95M |
December 31, 2021 | -117.29M |
September 30, 2021 | -126.03M |
June 30, 2021 | 67.86M |
March 31, 2021 | 20.34M |
December 31, 2020 | 73.43M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-126.03M
Minimum
Sep 2021
472.13M
Maximum
Mar 2023
120.90M
Average
67.86M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
Fonar Corp | -8.460M |
XWELL Inc | 0.008M |
ProPhase Labs Inc | 5.757M |
Applied DNA Sciences Inc | -0.0351M |
Veracyte Inc | 2.837M |